Price (delayed)
$1.11
Market cap
$12.13M
P/E Ratio
0.18
Dividend/share
N/A
EPS
$6.16
Enterprise value
$2.14M
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers
There are no recent dividends present for ACRX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.